MaxWell Biosystems is a direct peer to 3Brain in the high-density MEA market, supplying ex vivo electrophysiology tools for neuroscience and drug discovery. Its differentiation lies in cell-level recording and stimulation performance, making it infrastructure for pharma and research rather than a translational neurotech company.